Genotyping of Iranian Plasmodium vivax populations by using circumsporozoite protein gene (CSP) marker
Publish place: 04th National Biotechnology Congress of Iran
Publish Year: 1384
نوع سند: مقاله کنفرانسی
زبان: English
View: 1,902
This Paper With 5 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
NBCI04_270
تاریخ نمایه سازی: 30 دی 1386
Abstract:
Although circumsporozoite protein of Plasmodium vivax (Pvcsp) has been considered to be a potential vaccine candidate, there was no information about the sequence variation in CSP of Iranian P. vivax. In current study, the prevalence of two types of Pvcsp was determined by PCR-RPLP in 374 P. vivax infected patients. In north, with one exception, all parasites were VK210, however, in south both types were present. Mixed infections were common in south (12%), but it has not been observed in northern isolates. We also examined the genetic diversity of Pvcsp gene by sequencing analysis of 137 out of 374 field isolates obtained from resurgent parasite in north and endemic areas, in south of Iran. We have also found very limited polymorphism in the non-repetitive region of the gene in all isolates. However, repeated region of all sequenced samples showed variation in number of repeat, and also base substitutions was occurred which suggested that point mutation have caused the emergence of the variant sequence in Iranian isolates. Also such variation was much more in VK210 type than in those of VK247 type and also in southern isolates comparing to north. We also reported one novel sequence with new mutation (A/P) from southern isolate. Also few isolates have 2 copies of 19 AA insertions in post-repeated region, which has not been reported previously. The sequence data reported here provide more genetic information on P. vivax populations particularly from central Asia for the first time, which has also important implications for both practical measures aimed at developing control programs, and on future field-based vaccine trials with Pvcs protein antigen.
Keywords:
Authors
Akram Abouie Mehrizi
Malaria Research Group (MRG), Biotechnology Department, Pasteur Institute of Iran, Tehran
Parin Naimi
Malaria Research Group (MRG), Biotechnology Department, Pasteur Institute of Iran, Tehran
Navid Diparast Djadid
Malaria Research Group (MRG), Biotechnology Department, Pasteur Institute of Iran, Tehran
Ahmad Raeisi
Manager of Malaria Control Programme, Iran, Center for Diseases Management and Control (CDMC)
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :